Phase I trial of ALKS 8700 to treat multiple sclerosis begin

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Phase I trial of ALKS 8700 to treat multiple sclerosis begin

Post by MSUK »

Phase I trial of ALKS 8700 to treat multiple sclerosis begins

Ireland-based biopharmaceutical firm Alkermes has started a Phase I clinical trial of ALKS 8700, a novel monomethyl fumarate (MMF) molecule being developed for the treatment of multiple sclerosis (MS).

The trial will assess the safety, tolerability and pharmacokinetics of several oral formulations of ALKS 8700 compared to both placebo and active control groups in approximately 125 healthy volunteers......... Read More - http://www.ms-uk.org/emergingtherapies
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Drug Pipeline”